Thromboprophylaxis in hip fracture surgery: A pilot study comparing danaparoid, enoxaparin and dalteparin

Haemostasis

Volumn 29, Issue 6, 2000, Pages 310-317

  Bergqvist, David ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dalteparin; Danaparoid; Deep vein thrombosis; Enoxaparin; Hip fracture; Thromboprophylaxis; Venography; Venous thromboembolism

Indexed keywords

DALTEPARIN; DANAPAROID; ENOXAPARIN;

ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHLEBOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THROMBOEMBOLISM; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTITHROMBIN III; BLOOD LOSS, SURGICAL; CHONDROITIN SULFATES; DALTEPARIN; DERMATAN SULFATE; DRUG COMBINATIONS; DRUG EVALUATION; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEMORRHAGE; HEPARITIN SULFATE; HIP FRACTURES; HUMANS; INCIDENCE; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0343627727     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bergqvist D: Postoperative Thromboembolism. Frequency, Etiology, Prophylaxis. Berlin, Springer, Berlin, 1983.
2. Sevitt S, Gallagher NG: Prevention of venous thrombosis and pulmonary embolism in injured patients: A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur. Lancet 1959;ii:981-989.
3. Lassen MR, Borris LC, Christiansen HM, Moller-Larsen F, Knudsen V, Boris P, Nehen A-M, Jurik A-G, de Carvalho A, Nielsen B, Lucht K: Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine. Arch Orthop Trauma Surg 1989;108:10-13.
4. Jørgensen LN, Wille-Jørgensen PW, Hauch O: Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993;80:689-704.
5. Bergqvist D, Kettunen K, Fredin H, Faunø P, Suomalainen O, Soimakallio S, Karjalaincn P, Cederholm C, Jensen LJ, Justesen T, Stiekema JCJ: Thromboprophylaxis in patients with hip fractures: A prospective, randomized, comparative study between Org 10172 and dextran 70. Surgery 1991;109:617-622.
6. Gerhardt N, Yett HS, Robertson LK, Lee MA, Smith M, Salzman E: Low molecular weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip. J Bone Joint Surg 1991;73A:494-502.
7. Barsotti J, Gruel Y, Rosset P, Favard L, Dabo B, Andren J, Delahousse B, Leroy J: Comparative double-blind study of two dosage regimens of low-molecular weight heparin in elderly patients with a fracture of the neck of the femur. J Orthop Trauma 1990;4:371-375.
8. Monreal M, Lafoz E, Navarro, Granero X, Caja V, Caceres E, Salvador R. Ruiz J: A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture. J Trauma 1989;29:873-875.
9. Faunø P, Suomalainen O, Bergqvist D, Fredin H, Kettunen K, Soimakallio S, Cederholm C, Karjalainen P, Vissinger H, Justesen T: The use of fibrinogen uptake test in screening for deep vein thrombosis in patients with hip fracture. Thromb Res 1990;60:185-190.
10. Lensing AW, Büller HR, Prandoni P, Batchelor D, Molenaar AH, Cogo A, Vigo M, Huisman PM, ten Cate JW: Contrast venography, the gold standard for the diagnosis of deep-vein thrombosis: Improvement in observer agreement. Thromb Haemost 1992;67:8-12.
11. 125I-Fibrinogcn leg scanning: Reassessment of its role for the diagnosis of venous thrombosis in post-operative patients. Thromb Haemost 1993;69: 2-7.
12. Kretschmer G, Wentzl E, Schemper M: Influence of postoperative anticoagulant treatment on patient survival after femoro-popliteal vein bypass surgery. Lancet 1988;i:797-799.
13. Hull RD, Raskob GE, Pinco GF, Green D, Trowbridge AA, Elliot CG, Lerner RG, Hall J, Sparling T, Brettell HR, Norton J, Carter CJ, George R, Merli G, Ward J, Mayo W, Rosenbloom D, Brant R: Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992;67:8-12.
14. Prandoni P, Lensing AWA, Büller HR, Cogo A, Prins M, Cattelan A, Cuppini S, Noventu F, ten Cate J: Comparison of subcutaenous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 1992;339:441-445.